Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asym./Biol. Unit
(-)Asym./Biol. Unit - sites
collapse expand < >
Image Asym./Biol. Unit
Asym./Biol. Unit  (Jmol Viewer)
Image Asym./Biol. Unit - sites
Asym./Biol. Unit - sites  (Jmol Viewer)

(-) Description

Title :  STRUCTURE OF HUMAN INOS HEME DOMAIN IN COMPLEX WITH (R)-6-( 3-AMINO-2-(5-(2-(6-AMINO-4- METHYLPYRIDIN-2-YL)ETHYL) PYRIDIN-3-YL)PROPYL)-4-METHYLPYRIDIN-2-AMINE
 
Authors :  H. Li, T. L. Poulos
Date :  03 Apr 14  (Deposition) - 13 Aug 14  (Release) - 03 Sep 14  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  3.16
Chains :  Asym./Biol. Unit :  A,B,C,D
Keywords :  Oxidoreductase, Inhibitor Complex (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  H. Li, J. Jamal, S. L. Delker, C. Plaza, H. Ji, Q. Jing, H. Huang, S. Kang, R. B. Silverman, T. L. Poulos
Mobility Of A Conserved Tyrosine Residue Controls Isoform- Dependent Enzyme-Inhibitor Interactions In Nitric Oxide Synthases.
Biochemistry V. 53 5272 2014
PubMed-ID: 25089924  |  Reference-DOI: 10.1021/BI500561H

(-) Compounds

Molecule 1 - NITRIC OXIDE SYNTHASE, INDUCIBLE
    ChainsA, B, C, D
    EC Number1.14.13.39
    EngineeredYES
    Expression SystemESCHERICHIA COLI
    Expression System StrainBL21(DE3)
    Expression System Taxid469008
    Expression System VectorPCWORI
    Expression System Vector TypePLASMID
    FragmentHEME DOMAIN, RESIDUES 74-504
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymHEPATOCYTE NOS, HEP-NOS, INDUCIBLE NO SYNTHASE, INDUCIBLE NOS, INOS, NOS TYPE II, PEPTIDYL-CYSTEINE S-NITROSYLASE NOS2, INDUCIBLE NITRIC OXIDE SYNTHASE

 Structural Features

(-) Chains, Units

  1234
Asymmetric/Biological Unit ABCD

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (5, 25)

Asymmetric/Biological Unit (5, 25)
No.NameCountTypeFull Name
1GOL4Ligand/IonGLYCEROL
2H4B4Ligand/Ion5,6,7,8-TETRAHYDROBIOPTERIN
3HEM4Ligand/IonPROTOPORPHYRIN IX CONTAINING FE
4S714Ligand/Ion(R)-6-(3-AMINO-2-(5-(2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL)PYRIDIN-3-YL)PROPYL)-4-METHYLPYRIDIN-2-AMINE
5SO49Ligand/IonSULFATE ION

(-) Sites  (25, 25)

Asymmetric Unit (25, 25)
No.NameEvidenceResiduesDescription
01AC1SOFTWARETRP A:194 , CYS A:200 , GLN A:205 , SER A:242 , PHE A:369 , ASN A:370 , GLY A:371 , TRP A:372 , GLU A:377 , TRP A:463 , TYR A:489 , TYR A:491 , H4B A:600 , S71 A:800BINDING SITE FOR RESIDUE HEM A 550
02AC2SOFTWARESER A:118 , MET A:120 , ARG A:381 , ILE A:462 , TRP A:463 , HEM A:550 , S71 A:800 , TRP B:461 , PHE B:476 , HIS B:477 , GLU B:479BINDING SITE FOR RESIDUE H4B A 600
03AC3SOFTWAREMET A:120 , THR A:121 , GLN A:263 , PRO A:350 , TRP A:372 , GLU A:377 , TYR A:491 , HEM A:550 , H4B A:600 , GOL A:880 , TRP B:90BINDING SITE FOR RESIDUE S71 A 800
04AC4SOFTWAREGLN A:263 , ARG A:266 , ALA A:282 , S71 A:800BINDING SITE FOR RESIDUE GOL A 880
05AC5SOFTWAREGLY A:300 , ARG A:301 , PHE A:302BINDING SITE FOR RESIDUE SO4 A 910
06AC6SOFTWARETYR A:336 , GLU A:337 , TRP A:338 , ARG C:340BINDING SITE FOR RESIDUE SO4 A 920
07AC7SOFTWAREASN A:236 , ASN A:239 , ASN D:236 , ASN D:239BINDING SITE FOR RESIDUE SO4 A 930
08AC8SOFTWARETRP B:194 , CYS B:200 , ILE B:201 , GLN B:205 , PHE B:369 , ASN B:370 , GLY B:371 , TRP B:372 , GLU B:377 , TRP B:463 , TYR B:489 , TYR B:491 , H4B B:600 , S71 B:800BINDING SITE FOR RESIDUE HEM B 550
09AC9SOFTWARETRP A:461 , PHE A:476 , HIS A:477 , GLN A:478 , GLU A:479 , SER B:118 , MET B:120 , ARG B:381 , ILE B:462 , TRP B:463 , HEM B:550 , S71 B:800BINDING SITE FOR RESIDUE H4B B 600
10BC1SOFTWARETRP A:90 , GLN B:263 , ARG B:266 , VAL B:352 , TRP B:372 , GLU B:377 , TRP B:463 , TYR B:491 , HEM B:550 , H4B B:600 , GOL B:880BINDING SITE FOR RESIDUE S71 B 800
11BC2SOFTWAREARG B:266 , ALA B:282 , S71 B:800BINDING SITE FOR RESIDUE GOL B 880
12BC3SOFTWAREGLY B:300 , ARG B:301BINDING SITE FOR RESIDUE SO4 B 910
13BC4SOFTWARELYS B:335 , GLU B:337 , TRP B:338BINDING SITE FOR RESIDUE SO4 B 920
14BC5SOFTWARETRP C:194 , CYS C:200 , ILE C:201 , GLN C:205 , SER C:242 , PHE C:369 , ASN C:370 , GLY C:371 , TRP C:372 , GLU C:377 , TRP C:463 , TYR C:489 , TYR C:491 , H4B C:600 , S71 C:800BINDING SITE FOR RESIDUE HEM C 550
15BC6SOFTWARESER C:118 , MET C:120 , ARG C:381 , ILE C:462 , TRP C:463 , HEM C:550 , S71 C:800 , TRP D:461 , PHE D:476 , HIS D:477 , GLN D:478 , GLU D:479BINDING SITE FOR RESIDUE H4B C 600
16BC7SOFTWAREMET C:120 , THR C:121 , GLN C:263 , PRO C:350 , TRP C:372 , GLU C:377 , TRP C:463 , TYR C:491 , HEM C:550 , H4B C:600 , GOL C:880 , TRP D:90BINDING SITE FOR RESIDUE S71 C 800
17BC8SOFTWAREARG C:266 , ALA C:282 , S71 C:800BINDING SITE FOR RESIDUE GOL C 880
18BC9SOFTWAREGLY C:300 , ARG C:301BINDING SITE FOR RESIDUE SO4 C 910
19CC1SOFTWARELYS C:335 , TYR C:336 , GLU C:337 , TRP C:338BINDING SITE FOR RESIDUE SO4 C 920
20CC2SOFTWARETRP D:194 , CYS D:200 , GLN D:205 , PHE D:369 , ASN D:370 , GLY D:371 , TRP D:372 , GLU D:377 , TRP D:463 , TYR D:491 , H4B D:600 , S71 D:800BINDING SITE FOR RESIDUE HEM D 550
21CC3SOFTWARETRP C:461 , PHE C:476 , HIS C:477 , GLN C:478 , SER D:118 , MET D:120 , ARG D:381 , ILE D:462 , TRP D:463 , HEM D:550 , S71 D:800BINDING SITE FOR RESIDUE H4B D 600
22CC4SOFTWARETRP C:90 , MET D:120 , THR D:121 , GLN D:263 , PRO D:350 , TRP D:372 , GLU D:377 , TYR D:491 , HEM D:550 , H4B D:600 , GOL D:880BINDING SITE FOR RESIDUE S71 D 800
23CC5SOFTWAREARG D:266 , ALA D:282 , S71 D:800BINDING SITE FOR RESIDUE GOL D 880
24CC6SOFTWAREARG D:301BINDING SITE FOR RESIDUE SO4 D 910
25CC7SOFTWAREARG B:340 , LYS D:335 , TYR D:336 , GLU D:337 , TRP D:338BINDING SITE FOR RESIDUE SO4 D 920

(-) SS Bonds  (0, 0)

(no "SS Bond" information available for 4CX7)

(-) Cis Peptide Bonds  (4, 4)

Asymmetric/Biological Unit
No.Residues
1Ser A:486 -Pro A:487
2Ser B:486 -Pro B:487
3Ser C:486 -Pro C:487
4Ser D:486 -Pro D:487

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (1, 4)

Asymmetric/Biological Unit (1, 4)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_024548R221WNOS2_HUMANPolymorphism3730017A/B/C/DR221W

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (1, 4)

Asymmetric/Biological Unit (1, 4)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1NOSPS60001 Nitric oxide synthase (NOS) signature.NOS2_HUMAN199-206
 
 
 
  4A:199-206
B:199-206
C:199-206
D:199-206

(-) Exons   (10, 40)

Asymmetric/Biological Unit (10, 40)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1bENST000003137351bENSE00001842263chr17:26127525-26127365161NOS2_HUMAN-00--
1.2ENST000003137352ENSE00001302992chr17:26125908-26125726183NOS2_HUMAN1-37370--
1.3ENST000003137353ENSE00001327291chr17:26116714-2611663085NOS2_HUMAN37-65290--
1.4ENST000003137354ENSE00001310953chr17:26115957-26115835123NOS2_HUMAN66-106414A:83-106
B:83-106
C:83-106
D:83-106
24
24
24
24
1.5ENST000003137355ENSE00001347946chr17:26114852-26114704149NOS2_HUMAN107-156504A:107-156 (gaps)
B:107-156 (gaps)
C:107-156 (gaps)
D:107-156 (gaps)
50
50
50
50
1.6ENST000003137356ENSE00001312300chr17:26110132-26109970163NOS2_HUMAN156-210554A:156-210
B:156-210
C:156-210
D:156-210
55
55
55
55
1.7ENST000003137357ENSE00000705157chr17:26109132-2610904192NOS2_HUMAN211-241314A:211-241
B:211-241
C:211-241
D:211-241
31
31
31
31
1.8bENST000003137358bENSE00001126954chr17:26108203-26108062142NOS2_HUMAN241-288484A:241-288
B:241-288
C:241-288
D:241-288
48
48
48
48
1.9bENST000003137359bENSE00001251789chr17:26107932-26107793140NOS2_HUMAN289-335474A:289-335
B:289-335
C:289-335
D:289-335
47
47
47
47
1.10ENST0000031373510ENSE00001126938chr17:26106082-26105908175NOS2_HUMAN335-393594A:335-393
B:335-393
C:335-393
D:335-393
59
59
59
59
1.11ENST0000031373511ENSE00000704841chr17:26105817-26105716102NOS2_HUMAN394-427344A:394-427
B:394-427
C:394-427
D:394-427
34
34
34
34
1.12ENST0000031373512ENSE00001312003chr17:26101477-26101283195NOS2_HUMAN428-492654A:428-492
B:428-492
C:428-492
D:428-492
65
65
65
65
1.13ENST0000031373513ENSE00000704507chr17:26100269-2610018783NOS2_HUMAN493-520284A:493-503
B:493-503
C:493-503
D:493-503
11
11
11
11
1.14ENST0000031373514ENSE00001327457chr17:26099478-26099334145NOS2_HUMAN520-568490--
1.15ENST0000031373515ENSE00000946394chr17:26098043-26097939105NOS2_HUMAN569-603350--
1.16ENST0000031373516ENSE00000406697chr17:26096610-2609656150NOS2_HUMAN604-620170--
1.17ENST0000031373517ENSE00001309781chr17:26096177-26096003175NOS2_HUMAN620-678590--
1.18ENST0000031373518ENSE00001347743chr17:26094863-26094731133NOS2_HUMAN679-723450--
1.19ENST0000031373519ENSE00001310933chr17:26093614-2609353679NOS2_HUMAN723-749270--
1.20ENST0000031373520ENSE00001126885chr17:26092742-26092561182NOS2_HUMAN749-810620--
1.21ENST0000031373521ENSE00001251604chr17:26091170-26091007164NOS2_HUMAN810-864550--
1.22ENST0000031373522ENSE00001292830chr17:26090031-26089824208NOS2_HUMAN865-934700--
1.23ENST0000031373523ENSE00001304187chr17:26088257-2608817088NOS2_HUMAN934-963300--
1.24ENST0000031373524ENSE00001328702chr17:26087770-26087649122NOS2_HUMAN963-1004420--
1.25ENST0000031373525ENSE00001788249chr17:26087204-26087056149NOS2_HUMAN1004-1053500--
1.26ENST0000031373526ENSE00001322003chr17:26086101-26085907195NOS2_HUMAN1054-1118650--
1.27ENST0000031373527ENSE00001704085chr17:26084379-26083792588NOS2_HUMAN1119-1153350--

(-) Sequences/Alignments

Asymmetric/Biological Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:414
 aligned with NOS2_HUMAN | P35228 from UniProtKB/Swiss-Prot  Length:1153

    Alignment length:421
                                    92       102       112       122       132       142       152       162       172       182       192       202       212       222       232       242       252       262       272       282       292       302       312       322       332       342       352       362       372       382       392       402       412       422       432       442       452       462       472       482       492       502 
           NOS2_HUMAN    83 RHVRIKNWGSGMTFQDTLHHKAKGILTCRSKSCLGSIMTPKSLTRGPRDKPTPPDELLPQAIEFVNQYYGSFKEAKIEEHLARVEAVTKEIETTGTYQLTGDELIFATKQAWRNAPRCIGRIQWSNLQVFDARSCSTAREMFEHICRHVRYSTNNGNIRSAITVFPQRSDGKHDFRVWNAQLIRYAGYQMPDGSIRGDPANVEFTQLCIDLGWKPKYGRFDVVPLVLQANGRDPELFEIPPDLVLEVAMEHPKYEWFRELELKWYALPAVANMLLEVGGLEFPGCPFNGWYMGTEIGVRDFCDVQRYNILEEVGRRMGLETHKLASLWKDQAVVEINIAVLHSFQKQNVTIMDHHSAAESFMKYMQNEYRSRGGCPADWIWLVPPMSGSITPVFHQEMLNYVLSPFYYYQVEAWKTHVWQD 503
               SCOP domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ..eeee......eeeehhhhhh...-------.......hhhh.........hhhhhhhhhhhhhhhhhh.....hhhhhhhhhhhhhhhhhhhh....hhhhhhhhhhhhhhh...hhhhhhh...eeee.....hhhhhhhhhhhhhhhhhhhhh...eeee...........ee.......eeeee.....eee...hhhhhhhhhhh.........ee..eeee......eee..hhhhh.eee.....hhhhhhhh.eee...ee...eeee..eee....ee...hhhhhhhhhhhh.....hhhhhhhhhh....hhhhhhhhhhhhhhhhhhhhhhhhh.....hhhhhhhhhhhhhhhhhhhhh....hhhhhh...hhhhhhhhh..........eee...hhhhh..... Sec.struct. author
                 SAPs(SNPs) ------------------------------------------------------------------------------------------------------------------------------------------W------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ SAPs(SNPs)
                    PROSITE --------------------------------------------------------------------------------------------------------------------NOS     --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.4  PDB: A:83-106 Exon 1.5  PDB: A:107-156 (gaps) UniProt: 107-156  ------------------------------------------------------Exon 1.7  PDB: A:211-241       ---------------------------------------------------------------------------------------------Exon 1.10  PDB: A:335-393 UniProt: 335-393                 Exon 1.11  PDB: A:394-427         Exon 1.12  PDB: A:428-492 UniProt: 428-492                       Exon 1.13   Transcript 1 (1)
           Transcript 1 (2) -------------------------------------------------------------------------Exon 1.6  PDB: A:156-210 UniProt: 156-210              ------------------------------Exon 1.8b  PDB: A:241-288 UniProt: 241-288      Exon 1.9b  PDB: A:289-335 UniProt: 289-335     ------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Transcript 1 (2)
                 4cx7 A  83 RHVRIKNWGSGMTFQDTLHHKAKGI-------CLGSIMTPKSLTRGPRDKPTPPDELLPQAIEFVNQYYGSFKEAKIEEHLARVEAVTKEIETTGTYQLTGDELIFATKQAWRNAPRCIGRIQWSNLQVFDARSCSTAREMFEHICRHVRYSTNNGNIRSAITVFPQRSDGKHDFRVWNAQLIRYAGYQMPDGSIRGDPANVEFTQLCIDLGWKPKYGRFDVVPLVLQANGRDPELFEIPPDLVLEVAMEHPKYEWFRELELKWYALPAVANMLLEVGGLEFPGCPFNGWYMGTEIGVRDFCDVQRYNILEEVGRRMGLETHKLASLWKDQAVVEINIAVLHSFQKQNVTIMDHHSAAESFMKYMQNEYRSRGGCPADWIWLVPPMSGSITPVFHQEMLNYVLSPFYYYQVEAWKTHVWQD 503
                                    92       102    |    -  |    122       132       142       152       162       172       182       192       202       212       222       232       242       252       262       272       282       292       302       312       322       332       342       352       362       372       382       392       402       412       422       432       442       452       462       472       482       492       502 
                                                  107     115                                                                                                                                                                                                                                                                                                                                                                                                    

Chain B from PDB  Type:PROTEIN  Length:414
 aligned with NOS2_HUMAN | P35228 from UniProtKB/Swiss-Prot  Length:1153

    Alignment length:421
                                    92       102       112       122       132       142       152       162       172       182       192       202       212       222       232       242       252       262       272       282       292       302       312       322       332       342       352       362       372       382       392       402       412       422       432       442       452       462       472       482       492       502 
           NOS2_HUMAN    83 RHVRIKNWGSGMTFQDTLHHKAKGILTCRSKSCLGSIMTPKSLTRGPRDKPTPPDELLPQAIEFVNQYYGSFKEAKIEEHLARVEAVTKEIETTGTYQLTGDELIFATKQAWRNAPRCIGRIQWSNLQVFDARSCSTAREMFEHICRHVRYSTNNGNIRSAITVFPQRSDGKHDFRVWNAQLIRYAGYQMPDGSIRGDPANVEFTQLCIDLGWKPKYGRFDVVPLVLQANGRDPELFEIPPDLVLEVAMEHPKYEWFRELELKWYALPAVANMLLEVGGLEFPGCPFNGWYMGTEIGVRDFCDVQRYNILEEVGRRMGLETHKLASLWKDQAVVEINIAVLHSFQKQNVTIMDHHSAAESFMKYMQNEYRSRGGCPADWIWLVPPMSGSITPVFHQEMLNYVLSPFYYYQVEAWKTHVWQD 503
               SCOP domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ..eeee......eeeehhhhhh...-------.......hhhh.........hhhhhhhhhhhhhhhhhhhh...hhhhhhhhhhhhhhhhhhhh....hhhhhhhhhhhhhhh...hhhhhhh...eeee.....hhhhhhhhhhhhhhhhhhhhh...eeee...........ee.........eee.....eee...hhhhhhhhhhh.............eeee.....eeee..hhhhh.eee.....hhhhhhhh.eee...ee...eeee..eee....ee..eehhhhhh..........hhhhhhhhh.....hhhhhhhhhhhhhhhhhhhhhhhhh...eehhhhhhhhhhhhhhhhhhhhh....hhhhhh...hhhhhhhhh..........eee...hhhhhh.... Sec.struct. author
                 SAPs(SNPs) ------------------------------------------------------------------------------------------------------------------------------------------W------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ SAPs(SNPs)
                    PROSITE --------------------------------------------------------------------------------------------------------------------NOS     --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.4  PDB: B:83-106 Exon 1.5  PDB: B:107-156 (gaps) UniProt: 107-156  ------------------------------------------------------Exon 1.7  PDB: B:211-241       ---------------------------------------------------------------------------------------------Exon 1.10  PDB: B:335-393 UniProt: 335-393                 Exon 1.11  PDB: B:394-427         Exon 1.12  PDB: B:428-492 UniProt: 428-492                       Exon 1.13   Transcript 1 (1)
           Transcript 1 (2) -------------------------------------------------------------------------Exon 1.6  PDB: B:156-210 UniProt: 156-210              ------------------------------Exon 1.8b  PDB: B:241-288 UniProt: 241-288      Exon 1.9b  PDB: B:289-335 UniProt: 289-335     ------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Transcript 1 (2)
                 4cx7 B  83 RHVRIKNWGSGMTFQDTLHHKAKGI-------CLGSIMTPKSLTRGPRDKPTPPDELLPQAIEFVNQYYGSFKEAKIEEHLARVEAVTKEIETTGTYQLTGDELIFATKQAWRNAPRCIGRIQWSNLQVFDARSCSTAREMFEHICRHVRYSTNNGNIRSAITVFPQRSDGKHDFRVWNAQLIRYAGYQMPDGSIRGDPANVEFTQLCIDLGWKPKYGRFDVVPLVLQANGRDPELFEIPPDLVLEVAMEHPKYEWFRELELKWYALPAVANMLLEVGGLEFPGCPFNGWYMGTEIGVRDFCDVQRYNILEEVGRRMGLETHKLASLWKDQAVVEINIAVLHSFQKQNVTIMDHHSAAESFMKYMQNEYRSRGGCPADWIWLVPPMSGSITPVFHQEMLNYVLSPFYYYQVEAWKTHVWQD 503
                                    92       102    |    -  |    122       132       142       152       162       172       182       192       202       212       222       232       242       252       262       272       282       292       302       312       322       332       342       352       362       372       382       392       402       412       422       432       442       452       462       472       482       492       502 
                                                  107     115                                                                                                                                                                                                                                                                                                                                                                                                    

Chain C from PDB  Type:PROTEIN  Length:414
 aligned with NOS2_HUMAN | P35228 from UniProtKB/Swiss-Prot  Length:1153

    Alignment length:421
                                    92       102       112       122       132       142       152       162       172       182       192       202       212       222       232       242       252       262       272       282       292       302       312       322       332       342       352       362       372       382       392       402       412       422       432       442       452       462       472       482       492       502 
           NOS2_HUMAN    83 RHVRIKNWGSGMTFQDTLHHKAKGILTCRSKSCLGSIMTPKSLTRGPRDKPTPPDELLPQAIEFVNQYYGSFKEAKIEEHLARVEAVTKEIETTGTYQLTGDELIFATKQAWRNAPRCIGRIQWSNLQVFDARSCSTAREMFEHICRHVRYSTNNGNIRSAITVFPQRSDGKHDFRVWNAQLIRYAGYQMPDGSIRGDPANVEFTQLCIDLGWKPKYGRFDVVPLVLQANGRDPELFEIPPDLVLEVAMEHPKYEWFRELELKWYALPAVANMLLEVGGLEFPGCPFNGWYMGTEIGVRDFCDVQRYNILEEVGRRMGLETHKLASLWKDQAVVEINIAVLHSFQKQNVTIMDHHSAAESFMKYMQNEYRSRGGCPADWIWLVPPMSGSITPVFHQEMLNYVLSPFYYYQVEAWKTHVWQD 503
               SCOP domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ..eeee......eeeehhhhhh...-------.......hhhh.........hhhhhhhhhhhhhhhhhh.....hhhhhhhhhhhhhhhhhhhh......hhhhhhhhhhhh......hhhhh...eeee.....hhhhhhhhhhhhhhhhhhhhh...eeee...........ee.........eee.....eee...hhhhhhhhhhh.............eeee.....eeee........eee.....hhhhhhhh.eee...ee..eeeee..eee....ee..eehhhhhhhhhhh.....hhhhhhhhh.....hhhhhhhhhhhhhhhhhhhhhhhhh...eehhhhhhhhhhhhhhhhhhhhh....hhhhhh...hhhhhhhhh..........eeee..hhhhhh.... Sec.struct. author
                 SAPs(SNPs) ------------------------------------------------------------------------------------------------------------------------------------------W------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ SAPs(SNPs)
                    PROSITE --------------------------------------------------------------------------------------------------------------------NOS     --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.4  PDB: C:83-106 Exon 1.5  PDB: C:107-156 (gaps) UniProt: 107-156  ------------------------------------------------------Exon 1.7  PDB: C:211-241       ---------------------------------------------------------------------------------------------Exon 1.10  PDB: C:335-393 UniProt: 335-393                 Exon 1.11  PDB: C:394-427         Exon 1.12  PDB: C:428-492 UniProt: 428-492                       Exon 1.13   Transcript 1 (1)
           Transcript 1 (2) -------------------------------------------------------------------------Exon 1.6  PDB: C:156-210 UniProt: 156-210              ------------------------------Exon 1.8b  PDB: C:241-288 UniProt: 241-288      Exon 1.9b  PDB: C:289-335 UniProt: 289-335     ------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Transcript 1 (2)
                 4cx7 C  83 RHVRIKNWGSGMTFQDTLHHKAKGI-------CLGSIMTPKSLTRGPRDKPTPPDELLPQAIEFVNQYYGSFKEAKIEEHLARVEAVTKEIETTGTYQLTGDELIFATKQAWRNAPRCIGRIQWSNLQVFDARSCSTAREMFEHICRHVRYSTNNGNIRSAITVFPQRSDGKHDFRVWNAQLIRYAGYQMPDGSIRGDPANVEFTQLCIDLGWKPKYGRFDVVPLVLQANGRDPELFEIPPDLVLEVAMEHPKYEWFRELELKWYALPAVANMLLEVGGLEFPGCPFNGWYMGTEIGVRDFCDVQRYNILEEVGRRMGLETHKLASLWKDQAVVEINIAVLHSFQKQNVTIMDHHSAAESFMKYMQNEYRSRGGCPADWIWLVPPMSGSITPVFHQEMLNYVLSPFYYYQVEAWKTHVWQD 503
                                    92       102    |    -  |    122       132       142       152       162       172       182       192       202       212       222       232       242       252       262       272       282       292       302       312       322       332       342       352       362       372       382       392       402       412       422       432       442       452       462       472       482       492       502 
                                                  107     115                                                                                                                                                                                                                                                                                                                                                                                                    

Chain D from PDB  Type:PROTEIN  Length:414
 aligned with NOS2_HUMAN | P35228 from UniProtKB/Swiss-Prot  Length:1153

    Alignment length:421
                                    92       102       112       122       132       142       152       162       172       182       192       202       212       222       232       242       252       262       272       282       292       302       312       322       332       342       352       362       372       382       392       402       412       422       432       442       452       462       472       482       492       502 
           NOS2_HUMAN    83 RHVRIKNWGSGMTFQDTLHHKAKGILTCRSKSCLGSIMTPKSLTRGPRDKPTPPDELLPQAIEFVNQYYGSFKEAKIEEHLARVEAVTKEIETTGTYQLTGDELIFATKQAWRNAPRCIGRIQWSNLQVFDARSCSTAREMFEHICRHVRYSTNNGNIRSAITVFPQRSDGKHDFRVWNAQLIRYAGYQMPDGSIRGDPANVEFTQLCIDLGWKPKYGRFDVVPLVLQANGRDPELFEIPPDLVLEVAMEHPKYEWFRELELKWYALPAVANMLLEVGGLEFPGCPFNGWYMGTEIGVRDFCDVQRYNILEEVGRRMGLETHKLASLWKDQAVVEINIAVLHSFQKQNVTIMDHHSAAESFMKYMQNEYRSRGGCPADWIWLVPPMSGSITPVFHQEMLNYVLSPFYYYQVEAWKTHVWQD 503
               SCOP domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ..eeee......eeeehhhhhh...-------.......hhhh.........hhhhhhhhhhhhhhhhhhh....hhhhhhhhhhhhhhhhhhhh....hhhhhhhhhhhhhhh.....hhhhh...eeee.....hhhhhhhhhhhhhhhhhhhhh...eeee...........ee.........eee.....eee...hhhhhhhhhhh.............eeee......eee..hhhhh.eee......hhhhhh..eee...ee..eeeee..eee....ee...hhhhhhhhhhhh.....hhhhhhhhh.....hhhhhhhhhhhhhhhhhhhhhhhh......hhhhhhhhhhhhhhhhhhhhh....hhhhhh...hhhhhhhhh..........eeee..hhhhhh.... Sec.struct. author
                 SAPs(SNPs) ------------------------------------------------------------------------------------------------------------------------------------------W------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ SAPs(SNPs)
                    PROSITE --------------------------------------------------------------------------------------------------------------------NOS     --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.4  PDB: D:83-106 Exon 1.5  PDB: D:107-156 (gaps) UniProt: 107-156  ------------------------------------------------------Exon 1.7  PDB: D:211-241       ---------------------------------------------------------------------------------------------Exon 1.10  PDB: D:335-393 UniProt: 335-393                 Exon 1.11  PDB: D:394-427         Exon 1.12  PDB: D:428-492 UniProt: 428-492                       Exon 1.13   Transcript 1 (1)
           Transcript 1 (2) -------------------------------------------------------------------------Exon 1.6  PDB: D:156-210 UniProt: 156-210              ------------------------------Exon 1.8b  PDB: D:241-288 UniProt: 241-288      Exon 1.9b  PDB: D:289-335 UniProt: 289-335     ------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Transcript 1 (2)
                 4cx7 D  83 RHVRIKNWGSGMTFQDTLHHKAKGI-------CLGSIMTPKSLTRGPRDKPTPPDELLPQAIEFVNQYYGSFKEAKIEEHLARVEAVTKEIETTGTYQLTGDELIFATKQAWRNAPRCIGRIQWSNLQVFDARSCSTAREMFEHICRHVRYSTNNGNIRSAITVFPQRSDGKHDFRVWNAQLIRYAGYQMPDGSIRGDPANVEFTQLCIDLGWKPKYGRFDVVPLVLQANGRDPELFEIPPDLVLEVAMEHPKYEWFRELELKWYALPAVANMLLEVGGLEFPGCPFNGWYMGTEIGVRDFCDVQRYNILEEVGRRMGLETHKLASLWKDQAVVEINIAVLHSFQKQNVTIMDHHSAAESFMKYMQNEYRSRGGCPADWIWLVPPMSGSITPVFHQEMLNYVLSPFYYYQVEAWKTHVWQD 503
                                    92       102    |    -  |    122       132       142       152       162       172       182       192       202       212       222       232       242       252       262       272       282       292       302       312       322       332       342       352       362       372       382       392       402       412       422       432       442       452       462       472       482       492       502 
                                                  107     115                                                                                                                                                                                                                                                                                                                                                                                                    

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (0, 0)

(no "SCOP Domain" information available for 4CX7)

(-) CATH Domains  (0, 0)

(no "CATH Domain" information available for 4CX7)

(-) Pfam Domains  (0, 0)

(no "Pfam Domain" information available for 4CX7)

(-) Gene Ontology  (50, 50)

Asymmetric/Biological Unit(hide GO term definitions)
Chain A,B,C,D   (NOS2_HUMAN | P35228)
molecular function
    GO:0010181    FMN binding    Interacting selectively and non-covalently with flavin mono nucleotide. Flavin mono nucleotide (FMN) is the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes.
    GO:0050661    NADP binding    Interacting selectively and non-covalently with nicotinamide-adenine dinucleotide phosphate, a coenzyme involved in many redox and biosynthetic reactions; binding may be to either the oxidized form, NADP+, or the reduced form, NADPH.
    GO:0034618    arginine binding    Interacting selectively and non-covalently with 2-amino-5-(carbamimidamido)pentanoic acid.
    GO:0005516    calmodulin binding    Interacting selectively and non-covalently with calmodulin, a calcium-binding protein with many roles, both in the calcium-bound and calcium-free states.
    GO:0050660    flavin adenine dinucleotide binding    Interacting selectively and non-covalently with FAD, flavin-adenine dinucleotide, the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes, in either the oxidized form, FAD, or the reduced form, FADH2.
    GO:0020037    heme binding    Interacting selectively and non-covalently with heme, any compound of iron complexed in a porphyrin (tetrapyrrole) ring.
    GO:0046872    metal ion binding    Interacting selectively and non-covalently with any metal ion.
    GO:0004517    nitric-oxide synthase activity    Catalysis of the reaction: L-arginine + n NADPH + n H+ + m O2 = citrulline + nitric oxide + n NADP+.
    GO:0016491    oxidoreductase activity    Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and becomes reduced.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0042803    protein homodimerization activity    Interacting selectively and non-covalently with an identical protein to form a homodimer.
    GO:0005102    receptor binding    Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
    GO:0034617    tetrahydrobiopterin binding    Interacting selectively and non-covalently with a tetrahydrobiopterin, 5,6,7,8-tetrahydrobiopterin or a derivative thereof; tetrahydrobiopterins are enzyme cofactors that carry electrons in redox reactions.
biological process
    GO:0006527    arginine catabolic process    The chemical reactions and pathways resulting in the breakdown of arginine, 2-amino-5-(carbamimidamido)pentanoic acid.
    GO:0045454    cell redox homeostasis    Any process that maintains the redox environment of a cell or compartment within a cell.
    GO:0035690    cellular response to drug    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
    GO:0071346    cellular response to interferon-gamma    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-gamma stimulus. Interferon gamma is the only member of the type II interferon found so far.
    GO:0071222    cellular response to lipopolysaccharide    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
    GO:0007623    circadian rhythm    Any biological process in an organism that recurs with a regularity of approximately 24 hours.
    GO:0050829    defense response to Gram-negative bacterium    Reactions triggered in response to the presence of a Gram-negative bacterium that act to protect the cell or organism.
    GO:0042742    defense response to bacterium    Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism.
    GO:0002227    innate immune response in mucosa    Any process of the innate immune response that takes place in the mucosal tissues.
    GO:0072604    interleukin-6 secretion    The regulated release of interleukin-6 from a cell.
    GO:0072606    interleukin-8 secretion    The regulated release of interleukin-8 from a cell.
    GO:0045776    negative regulation of blood pressure    Any process in which the force of blood traveling through the circulatory system is decreased.
    GO:0010629    negative regulation of gene expression    Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
    GO:0042177    negative regulation of protein catabolic process    Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.
    GO:0006809    nitric oxide biosynthetic process    The chemical reactions and pathways resulting in the formation of nitric oxide, nitrogen monoxide (NO), a colorless gas only slightly soluble in water.
    GO:0007263    nitric oxide mediated signal transduction    Any intracellular signal transduction in which the signal is passed on within the cell via nitric oxide (NO). Includes synthesis of nitric oxide, receptors/sensors for nitric oxide (such as soluble guanylyl cyclase/sGC) and downstream effectors that further transmit the signal within the cell. Nitric oxide transmits its downstream effects through either cyclic GMP (cGMP)-dependent or independent mechanisms.
    GO:0055114    oxidation-reduction process    A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons.
    GO:0018119    peptidyl-cysteine S-nitrosylation    The covalent addition of a nitric oxide (NO) group to the sulphur (S) atom of a cysteine residue in a protein, to form peptidyl-S-nitrosyl-L-cysteine.
    GO:0031284    positive regulation of guanylate cyclase activity    Any process that activates or increases the frequency, rate or extent of guanylate cyclase activity.
    GO:0051712    positive regulation of killing of cells of other organism    Any process that activates or increases the frequency, rate or extent of the killing by an organism of cells in another organism.
    GO:0001912    positive regulation of leukocyte mediated cytotoxicity    Any process that activates or increases the frequency, rate or extent of leukocyte mediated cytotoxicity.
    GO:0032310    prostaglandin secretion    The regulated release of a prostaglandin, any of a group of biologically active metabolites which contain a cyclopentane ring, from a cell or a tissue.
    GO:0042127    regulation of cell proliferation    Any process that modulates the frequency, rate or extent of cell proliferation.
    GO:0043457    regulation of cellular respiration    Any process that modulates the frequency, rate or extent of cellular respiration, the enzymatic release of energy from organic compounds.
    GO:1900015    regulation of cytokine production involved in inflammatory response    Any process that modulates the frequency, rate or extent of cytokine production involved in inflammatory response.
    GO:0050796    regulation of insulin secretion    Any process that modulates the frequency, rate or extent of the regulated release of insulin.
    GO:0009617    response to bacterium    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a bacterium.
    GO:0001666    response to hypoxia    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
    GO:0032496    response to lipopolysaccharide    Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
    GO:0006801    superoxide metabolic process    The chemical reactions and pathways involving superoxide, the superoxide anion O2- (superoxide free radical), or any compound containing this species.
cellular component
    GO:0030863    cortical cytoskeleton    The portion of the cytoskeleton that lies just beneath the plasma membrane.
    GO:0005737    cytoplasm    All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
    GO:0005829    cytosol    The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
    GO:0005622    intracellular    The living contents of a cell; the matter contained within (but not including) the plasma membrane, usually taken to exclude large vacuoles and masses of secretory or ingested material. In eukaryotes it includes the nucleus and cytoplasm.
    GO:0005634    nucleus    A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
    GO:0048471    perinuclear region of cytoplasm    Cytoplasm situated near, or occurring around, the nucleus.
    GO:0005777    peroxisome    A small organelle enclosed by a single membrane, and found in most eukaryotic cells. Contains peroxidases and other enzymes involved in a variety of metabolic processes including free radical detoxification, lipid catabolism and biosynthesis, and hydrogen peroxide metabolism.

 Visualization

(-) Interactive Views

Asymmetric/Biological Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    GOL  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    H4B  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    HEM  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    S71  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    SO4  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
    AC2  [ RasMol ]  +environment [ RasMol ]
    AC3  [ RasMol ]  +environment [ RasMol ]
    AC4  [ RasMol ]  +environment [ RasMol ]
    AC5  [ RasMol ]  +environment [ RasMol ]
    AC6  [ RasMol ]  +environment [ RasMol ]
    AC7  [ RasMol ]  +environment [ RasMol ]
    AC8  [ RasMol ]  +environment [ RasMol ]
    AC9  [ RasMol ]  +environment [ RasMol ]
    BC1  [ RasMol ]  +environment [ RasMol ]
    BC2  [ RasMol ]  +environment [ RasMol ]
    BC3  [ RasMol ]  +environment [ RasMol ]
    BC4  [ RasMol ]  +environment [ RasMol ]
    BC5  [ RasMol ]  +environment [ RasMol ]
    BC6  [ RasMol ]  +environment [ RasMol ]
    BC7  [ RasMol ]  +environment [ RasMol ]
    BC8  [ RasMol ]  +environment [ RasMol ]
    BC9  [ RasMol ]  +environment [ RasMol ]
    CC1  [ RasMol ]  +environment [ RasMol ]
    CC2  [ RasMol ]  +environment [ RasMol ]
    CC3  [ RasMol ]  +environment [ RasMol ]
    CC4  [ RasMol ]  +environment [ RasMol ]
    CC5  [ RasMol ]  +environment [ RasMol ]
    CC6  [ RasMol ]  +environment [ RasMol ]
    CC7  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
    Ser A:486 - Pro A:487   [ RasMol ]  
    Ser B:486 - Pro B:487   [ RasMol ]  
    Ser C:486 - Pro C:487   [ RasMol ]  
    Ser D:486 - Pro D:487   [ RasMol ]  
 

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  4cx7
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  NOS2_HUMAN | P35228
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  1.14.13.39
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  (no 'MIM ID' available)
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  NOS2_HUMAN | P35228
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        NOS2_HUMAN | P352281nsi 2ll6 2nsi 3e7g 3ej8 3hr4 4nos

(-) Related Entries Specified in the PDB File

4cwv STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN IN COMPLEX WITH 4-METHYL-6-(((3R,4R)-4 -((5-(PYRIDIN-2-YL)PENTYL)OXY)PYRROLIDIN-3-YL) METHYL)PYRIDIN-2-AMINE
4cww STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN IN COMPLEX WITH 4-METHYL-6-(((3R,4R)-4 -((5-(4-METHYLPYRIDIN-2-YL)PENTYL)OXY)PYRROLIDIN-3- YL)METHYL)PYRIDIN-2-AMINE
4cwx STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN IN COMPLEX WITH 6-(((3R,4R)-4-((5-(6- AMINOPYRIDIN-2-YL)PENTYL)OXY)PYRROLIDIN-3-YL)METHYL)- 4-METHYLPYRIDIN-2-AMINE
4cwy STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN IN COMPLEX WITH 6-(5-(((3R,4R)-4-((6- AMINO-4-METHYLPYRIDIN-2-YL)METHYL)PYRROLIDIN-3-YL) OXY)PENTYL)-4-METHYLPYRIDIN-2-AMINE
4cwz STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE Y477A MUTANT HEME DOMAIN IN COMPLEX WITH 4-METHYL-6 -(((3R,4R)-4-((5-(4-METHYLPYRIDIN-2-YL)PENTYL)OXY) PYRROLIDIN-3-YL)METHYL)PYRIDIN-2-AMINE
4cx0 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE Y477A MUTANT HEME DOMAIN IN COMPLEX WITH 6-((((3S, 5R)-5-(((6-AMINO-4-METHYLPYRIDIN-2-YL)METHOXY)METHYL )PYRROLIDIN-3-YL)OXY)METHYL)-4-METHYLPYRIDIN-2-AMINE
4cx1 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE L111A MUTANT HEME DOMAIN IN COMPLEX WITH 4-METHYL-6 -(((3R,4R)-4-((5-(4-METHYLPYRIDIN-2-YL)PENTYL)OXY) PYRROLIDIN-3-YL)METHYL)PYRIDIN-2-AMINE
4cx2 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN IN COMPLEX WITH 6-(5-(((3R,4R)-4-((6- AMINO-4-METHYLPYRIDIN-2-YL)METHYL)PYRROLIDIN-3-YL) OXY)PENTYL)-4-METHYLPYRIDIN-2-AMINE
4cx3 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE M336V D597N MUTANT HEME DOMAIN IN COMPLEX WITH 4-METHYL-6 -(((3R,4R)-4-((5-(PYRIDIN-2-YL)PENTYL)OXY) PYRROLIDIN-3-YL)METHYL)PYRIDIN-2-AMINE
4cx4 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE M336V D597N MUTANT HEME DOMAIN IN COMPLEX WITH 4-METHYL-6 -(((3R,4R)-4-((5-(4-METHYLPYRIDIN-2-YL)PENTYL)OXY) PYRROLIDIN-3-YL)METHYL)PYRIDIN-2-AMINE
4cx5 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE H341L MUTANT HEME DOMAIN IN COMPLEX WITH 4-METHYL-6-(((3R ,4R)-4-((5-(PYRIDIN-2-YL)PENTYL)OXY)PYRROLIDIN-3- YL)METHYL)PYRIDIN-2-AMINE
4cx6 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE H341L MUTANT HEME DOMAIN IN COMPLEX WITH 6-((((3S, 5R)-5 -(((6-AMINO-4-METHYLPYRIDIN-2-YL)METHOXY)METHYL) PYRROLIDIN-3-YL)OXY)METHYL)-4-METHYLPYRIDIN-2-AMINE